1.  

Language	Japanese
The announcement title	JAID/JSC guidelines to treat urinary tract infections 2022: messages from the working group: Acute Bacterial Prostatitis, Acute Epididymitis
Academic Society name	The 110th Annual Meeting of the Japanese Urological Association
Conference Type	Domestic Society
Announcement form	Oral presentation
Presentation Type	Symposium/Workshop/Panel Discussion
Lecture Type	シンポジウム・ワークショップ パネル（指名）
Publisher and common publisher	Togo Yoshikazu, Kaizuka Yohei, Nagasawa Seiji, Yamamoto Shingo
Date	2023/04/21
Country	Japan
Venue (city and name of the country)	Kobe
Holding period	2023/04/20～2023/04/23
Society abstract	SY28-4 2023
Description	Acute bacterial prostatitis (ABP) and acute epididymitis (AE) are common urological diseases. While antibiotics administration is the primary treatment given, some important points should be kept in mind. The first step is determination of the causative microorganism. ABP is almost caused by Gram-negative bacilli, mainly E. coli. However, it is important to note that drug-resistant causative bacteria can increase following a lower urinary tract procedure. On the other hand, in AE patients, the frequency of causative bacteria varies depending on age. Sexually transmitted infections such as C. trachomatis and N. gonorrhoeae are often seen in younger patients, and the frequency of intestinal bacteria such as E. coli increases in the elderly. Next is selection of antibiotics. In mild to moderate conditions, both ABP and AE are recommended for treatment with oral quinolones. In acute inflammation, even β-lactam drugs show a high level of transferability to the prostate, so second- to fourth-generation cephem intravenous drugs are generally the first choice in severe cases. Such drugs are given as empiric therapy, though a switch to definitive therapy must be made as soon as drug sensitivity results of urine cultures submitted before starting treatment are known. The final step is consideration of the antibiotics administration period. For mild to moderate cases, that period is 14 days, while for severe cases, administration for a total of 14 to 28 days is recommended. We trust that the contents of this symposium will be helpful for your future practice.